Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
1d ago
KURA
Premium
Company Announcements
Kura Oncology Advances Precision Cancer Therapies
3d ago
KURA
Premium
Company Announcements
Kura Oncology’s Positive Outlook in Latest Earnings Call
4d ago
KURA
Premium
Ratings
Kura Oncology’s Promising Market Position and Anticipated Approval of Ziftomenib Boosts Buy Rating
4d ago
KURA
Premium
Ratings
Kura Oncology: Strategic Advancements and Financial Stability Drive Buy Rating
4d ago
KURA
Premium
Ratings
Kura Oncology: A Promising Investment with Strong Financials and Advancing Ziftomenib Program
4d ago
KURA
Premium
The Fly
Kura Oncology reports Q3 EPS (85c), consensus (68c)
4d ago
KURA
Premium
The Fly
Kura Oncology receives second $30M milestone payment from Kyowa Kirin pact
5d ago
KURA
Premium
Pre-Earnings
Kura Oncology (KURA) Q3 Earnings Cheat Sheet
11d ago
KURA
Premium
Ratings
Promising Prospects for Kura Oncology: Buy Rating Backed by Ziftomenib’s Safety and Market Potential
12d ago
KURA
Premium
Ratings
Kura Oncology’s Competitive Edge in AML Treatment: Favorable Safety Profile of Ziftomenib Drives Buy Rating
13d ago
KURA
Premium
Company Announcements
Kura Oncology Receives $30M Milestone Payment
15d ago
8K
KURA
Premium
The Fly
Kura Oncology receives $30M development milestone payment for ziftomenib
15d ago
KURA
Premium
Ratings
Promising Phase 1 Trial Results Bolster Buy Rating for Kura Oncology’s FTIs
19d ago
KURA
Premium
The Fly
Kura Oncology announces preliminary data from FTI programs
20d ago
KURA
Premium
The Fly
Kura Oncology management to meet with Cantor
23d ago
KURA
Premium
Company Announcements
Kura Oncology Expands Inducement Option Plan Shares
23d ago
8K
KURA
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
1M ago
KURA
Premium
The Fly
Kura Oncology, Kyowa Kirin doses first patient of KOMET-007 trial
1M ago
KURA
Premium
Ratings
Kura Oncology’s Promising Developments in AML Treatment: Buy Rating Affirmed by Joseph Pantginis
1M ago
KURA
Premium
The Fly
Kura Oncology announces first patient dosed in KOMET-017 clinical trial
1M ago
KURA
Premium
The Fly
Kura Oncology’s ziftomenib meets primary endpoint in AML study
1M ago
KURA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
